Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Alberico L. Catapano(University of Milan), Heribert Schunkert(German Centre for Cardiovascular Research), Henry N. Ginsberg(Columbia University), Olov Wiklund(Translational Therapeutics (United States)), Jay D. Horton(Center for Human Genetics), Bart van de Sluis(University of Groningen), Jane K. Stock(European Atherosclerosis Society), Robert A. Hegele(Western University), Frederick J. Raal(University of the Witwatersrand), Jan Borén(Göteborgs Stads), Ian Graham(Ottawa Hospital), Éric Bruckert(Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société), Stephen J. Nicholls(Australian Centre for Heart Health), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Ulrich Laufs(University Hospital Leipzig), M. John Chapman(University of Cambridge), Ronald M. Krauss(University of California System), Gerald F. Watts(Royal Perth Hospital), Børge G. Nordestgaard(Gentofte Hospital), Ulf Landmesser(Deutsches Herzzentrum der Charité), Sergio Fazio(Regeneron (United States)), Chris J. Packard(University of Glasgow), Lâle Tokgözoğlu(Hacettepe University), Kausik K. Ray(Imperial College London)
Cited by 3,824
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
|Journal of Clinical Investigation|2002|4k